Literature DB >> 2668458

Biochemical tests for pheochromocytoma: strategies in hypertensive patients.

M J Young1, C Dmuchowski, J W Wallis, G P Barnas, B Shapiro.   

Abstract

OBJECTIVE: To determine the optimal clinical strategy utilizing either 1) serum catecholamines, 2) urinary metanephrines, or 3) urinary vanillylmandelic acid measurements in the evaluation of hypertensive patients with suspected pheochromocytoma.
DESIGN: Prospective clinical determination of test-operating characteristics.
SETTING: Tertiary care university medical center. PATIENTS/PARTICIPANTS: 415 patients referred for evaluation of suspected pheochromocytoma.
INTERVENTIONS: All subjects had measurements of the three above-mentioned biochemical tests with the diagnosis of pheochromocytoma established by tissue confirmation.
RESULTS: All three biochemical tests were similar in sensitivity (0.70-0.75), specificity (0.90-0.95), and receiver operating characteristics. With an estimated disease prevalence of 5.9% in symptomatic hypertensive patients, the predictive value of any single negative test would be 98% in ruling out disease.
CONCLUSIONS: All three biochemical tests have similar performance characteristics and only a single test need be performed to exclude pheochromocytoma in most symptomatic hypertensive patients in a primary care population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668458     DOI: 10.1007/bf02597394

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  The estimation of catechol amines in urine.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1959-03-31

Review 2.  A critical review of diagnostic tests for pheochromocytoma.

Authors:  A Amery; J Conway
Journal:  Am Heart J       Date:  1967-01       Impact factor: 4.749

3.  The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. A review of ten years' experience.

Authors:  S E Gitlow; M Mendlowitz; L M Bertani
Journal:  Am J Cardiol       Date:  1970-09       Impact factor: 2.778

4.  Statistical approaches to the analysis of receiver operating characteristic (ROC) curves.

Authors:  B J McNeil; J A Hanley
Journal:  Med Decis Making       Date:  1984       Impact factor: 2.583

5.  An expert system which critiques patient workup: modeling conflicting expertise.

Authors:  P L Miller; S J Blumenfrucht; H R Black
Journal:  Comput Biomed Res       Date:  1984-12

6.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

7.  Plasma free and conjugated catecholamines in diagnosis and localisation of pheochromocytoma.

Authors:  D Ratge; G Baumgardt; E Knoll; H Wisser
Journal:  Clin Chim Acta       Date:  1983-08-31       Impact factor: 3.786

8.  Catecholamine measurements in phaeochromocytoma: a review.

Authors:  R C Causon; M J Brown
Journal:  Ann Clin Biochem       Date:  1982-11       Impact factor: 2.057

9.  Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations.

Authors:  P F Plouin; J M Duclos; J Menard; E Comoy; C Bohuon; J M Alexandre
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

10.  [Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)].

Authors:  P F Plouin; P Degoulet; A Tugayé; M B Ducrocq; J Ménard
Journal:  Nouv Presse Med       Date:  1981-03-07
View more
  4 in total

1.  Detecting pheochromocytoma: defining the most sensitive test.

Authors:  Ulrich Guller; Joe Turek; Steve Eubanks; Elizabeth R Delong; Daniel Oertli; Jerome M Feldman
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Screening for pheochromocytoma.

Authors:  J Whittle
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

3.  Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis.

Authors:  G P Bernini; M S Vivaldi; G F Argenio; A Moretti; M Sgrò; A Salvetti
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

4.  Lack of uniformity in the clinical approach to the interpretation of urinary catecholamines and their metabolites.

Authors:  W P Tormey; R J FitzGerald
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.